Skip to main content
Livermore
Livermore
ZHEN

Squarepoint Ops LLC

SEC CIK
0001642575
Latest filing
Aug 14, 2026

VKTX holding history

Viking Therapeutics, Inc. in every 13F filed by Squarepoint Ops LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

VKTX overviewAll 13F holders of VKTXFull Q2 2026 holdings

Shares (Q2 2026)
41,139
Value
$1.60M
% of portfolio
<0.1%
Quarters held
16
Since Q1 2021
Holdings of VKTX by Squarepoint Ops LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202641,139$1.60M<0.1%+41,139NewHolders
Q3 20250$00.0%−55,355−100.0%Sold outHolders
Q2 202555,355$1.47M<0.1%−383,576−87.4%ReducedHolders
Q1 2025438,931$10.6M<0.1%+171,626+64.2%AddedHolders
Q4 2024267,305$10.8M<0.1%+233,051+680.4%AddedHolders
Q3 202434,254$2.17M<0.1%−107,566−75.8%ReducedHolders
Q2 2024141,820$7.52M<0.1%+141,820NewHolders
Q1 20240$00.0%−50,603−100.0%Sold outHolders
Q4 202350,603$941.7K<0.1%+23,673+87.9%AddedHolders
Q3 202326,930$298.1K<0.1%+26,930NewHolders
Q2 20230$00.0%−26,063−100.0%Sold outHolders
Q1 202326,063$433.9K<0.1%+26,063NewHolders
Q4 20220$00.0%−14,382−100.0%Sold outHolders
Q3 202214,382$39.0K<0.1%−381−2.6%ReducedHolders
Q2 202214,763$43.0K<0.1%−3,077−17.2%ReducedHolders
Q1 202217,840$54.0K<0.1%−50,279−73.8%ReducedHolders
Q4 202168,119$313.0K<0.1%+37,704+124.0%AddedHolders
Q3 202130,415$191.0K<0.1%−68,751−69.3%ReducedHolders
Q2 202199,166$594.0K<0.1%−7,089−6.7%ReducedHolders
Q1 2021106,255$672.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.